https://kstockbriefing.com
![[Disclosure] Hyundai Motor (005380) – Future Business and Management Plan (Fair Disclosure) / 2025-01-23](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환-현대차.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor has disclosed its 2025 management guidance, setting annual sales targets at 4.17 million units, revenue growth at 3.0–4.0%, operating profit margin at 7.0–8.0%, and planned investments at KRW 16.9T. 📊 [Key Disclosure Contents & Major Figures Summary] 1. Key 2025 Management Guidance Targets (Note:…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor has set February 28, 2025, as the record date to determine shareholders eligible to receive the FY2024 year-end dividend. 📊 [Key Disclosure Contents & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Dividend Record Date and Eligible Shareholder Identification This…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor has resolved a year-end cash dividend of KRW 6,000 per common share for FY2024, totaling approximately KRW 1.57T. 📊 [Key Disclosure Contents & Major Figures Summary] 1. Dividend Per Share and Dividend Yield by Share Class 2. Annual Dividend Metrics & Notes 📝 Editor’s…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor has disclosed its Fair Trade Compliance Program (CP) operational results for Q4 2024 alongside its operational plan for 2025. 📊 [Key Disclosure Contents & Major Figures Summary] 1. Q4 2024 CP Operational Status 2. 2025 CP Operational Plan 📝 Editor’s Comment (Key Follow-up Checkpoint)…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary The company terminated its KRW 50.0B treasury stock acquisition trust contract with Hyundai Motor Securities due to contract expiration. The 434,200 treasury shares acquired under this trust will be returned to the company’s corporate account in cash and physical shares. 📊 [Key Disclosure Contents & Summary…
![[Disclosure] Samsung Biologics (207940) – Change of 15% or More in Revenue or Profit/Loss Structure (Large-Scale Company) / 2025-01-22](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-삼성바이오로직스.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed its FY2024 preliminary consolidated financial results, reporting revenue of KRW 4.547T (+23.1% YoY) and operating profit of KRW 1.320T (+18.5% YoY). 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring Revenue Changes and Upcoming Audit Report…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed its provisional Q4 and FY2024 consolidated financial results via fair disclosure, reporting Q4 revenue of KRW 1.256T (+17.04% YoY) and operating profit of KRW 325.7B (-6.94% YoY). Full-year 2024 cumulative revenue reached KRW 4.547T (+23.08% YoY) with operating profit of KRW 1.320T…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed its FY2025 consolidated revenue forecast of KRW 5.5705T (midpoint of the expected YoY growth range of +20% to +25%). The variance between the FY2024 revenue forecast and actual performance was 4.7%. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key…
![[Disclosure] Daeduck Electronics (353200) – Advance Notice of Earnings Release (Information Disclosure) / 2025-01-21](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환대덕전자.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Daeduck Electronics has announced in advance that it plans to disclose its provisional Q4 and FY2024 financial results on January 31, 2025. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Earnings Release Disclosure and Final Confirmed Figures Through…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Daeduck Electronics is hosting an Investor Relations (IR) event for domestic institutional investors to present its Q4 2024 financial results and business outlook. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of IR Presentation Materials and Confirmed Financial Results…